US Warrant News

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – Stockhouse

Ascent Solar Completes 12M Common Stock Issuance at $3.96MStockhouseAscent entered into the SPA with an Asian-based investor to sell 12 million shares of restricted common stock with no warrants at a fixed price of $0.33 per share. The first tranche of 4 million shares closed on July 29th, 2014. The second tranche … and more […]

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – Stockhouse Read More »

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – Rock Hill Herald (press release)

Ascent Solar Completes 12M Common Stock Issuance at $3.96MRock Hill Herald (press release)Ascent entered into the SPA with an Asian-based investor to sell 12 million shares of restricted common stock with no warrants at a fixed price of $0.33 per share. The first tranche of 4 million shares closed on July 29th, 2014. The second

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – Rock Hill Herald (press release) Read More »

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – MarketWatch

Ascent Solar Completes 12M Common Stock Issuance at $3.96MMarketWatchAscent entered into the SPA with an Asian-based investor to sell 12 million shares of restricted common stock with no warrants at a fixed price of $0.33 per share. The first tranche of 4 million shares closed on July 29th, 2014. The second tranche … …read more

Ascent Solar Completes 12M Common Stock Issuance at $3.96M – MarketWatch Read More »

TapImmune Inc. Announces $2 Million Registered Direct Offering – PharmiWeb.com (press release)

TapImmune Inc. Announces $2 Million Registered Direct OfferingPharmiWeb.com (press release)In addition the Company will issue to the investor warrants to purchase up to 1886793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to … and more …read

TapImmune Inc. Announces $2 Million Registered Direct Offering – PharmiWeb.com (press release) Read More »

TapImmune, Inc. Announces $2 Million Registered Direct Offering – Wall Street Journal

TapImmune, Inc. Announces $2 Million Registered Direct OfferingWall Street JournalIn addition, the Company will issue to the investor warrants to purchase up to 1,886,793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to … and more …read

TapImmune, Inc. Announces $2 Million Registered Direct Offering – Wall Street Journal Read More »

TapImmune, Inc. Announces $2 Million Registered Direct Offering – MarketWatch

TapImmune, Inc. Announces $2 Million Registered Direct OfferingMarketWatchIn addition, the Company will issue to the investor warrants to purchase up to 1,886,793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to … …read more

TapImmune, Inc. Announces $2 Million Registered Direct Offering – MarketWatch Read More »

Centrue Financial Corporation Announces Agreement for Proposed $75.0 … – CNNMoney

Centrue Financial Corporation Announces Agreement for Proposed $75.0 …CNNMoney… Company’s Series C Preferred Stock, cancellation and settlement of warrants to purchase the Company’s common stock held by the United States Department of Treasury, repayment or other settlement of the Company’s existing subordinated debt facility, … …read more

Centrue Financial Corporation Announces Agreement for Proposed $75.0 … – CNNMoney Read More »

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of … – MarketWatch

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of …MarketWatchThe warrant transactions could have a dilutive effect to the extent that the market price per share of Aegerion’s common stock exceeds the applicable strike price of the warrants on any expiration date of the warrants. In addition, if the initial … …read more

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of … – MarketWatch Read More »

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of … – MarketWatch

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of …MarketWatchThe warrant transactions could have a dilutive effect to the extent that the market price per share of Aegerion’s common stock exceeds the applicable strike price of the warrants on any expiration date of the warrants. In addition, if the initial … and more …read

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of … – MarketWatch Read More »

Scroll to Top